Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • The Inquiry Report
    • Additional Compensation Report
    • First Interim Report
    • Second Interim Report
    • Compensation Framework Study
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

The ERL was closely linked with the National Institute for Biological standards and Control and the Committee on Safety of Medicines, and represented on various DHSS and Medical Research Council committees concerned with immunisation.

Published on: 25 July, 2024

The Communicable Disease Report published the results of the CDSC surveillance scheme set up to monitor opportunistic infections and cases of Kaposi's sarcoma.

Published on: 25 July, 2024

The Microbiology of Food and the Environment and Communicable Disease division of the DHSS was responsible for the monitoring of infectious and communicable diseases, included those transmitted via blood transfusion and other blood products.

Published on: 25 July, 2024

The DHSS published a health circular which set out the main functions of the CDSC.

Published on: 25 July, 2024

Professor Palmer took up a post as regional epidemiologist for Wales. At the time, he was the only CDSC consultant epidemiologist in the regions. He was the first to be appointed through the CDSC training programme.

Published on: 25 July, 2024

CDSC Wales acted as an advisor to the Chief Medical Officer at the Welsh Office on the epidemiology and control of communicable diseases in Wales.

Published on: 25 July, 2024

After reorganisation, Northern Ireland set up four health and social service boards. There was no separate administration for family practitioner services. Instead, the functions typically associated with community health councils were carried out by district committees.

Published on: 25 July, 2024

After reorganisation, the Welsh Office combined the functions of a central government department and a regional health authority.

Published on: 25 July, 2024

The National Health Service (Scotland) Act 1972 established 15 health boards with no regional tier of administration. Local health councils were established to oversee family practitioner services.

Published on: 25 July, 2024

The Communicable Disease Surveillance Centre for Northern Ireland was established.

Published on: 25 July, 2024

The PHLS Working Party on Haemodialysis Units published a report which measured the use of immunoglobulin to prevent the spread of hepatitis.

Published on: 25 July, 2024

The renal unit at London Hospital published a document outlining the precautions taken to prevent hepatitis in the dialysis and transplantation unit.

Published on: 25 July, 2024

The World Health Organization Expert Committee on Hepatitis First Report published in the WHO Technical Report series recommended that "both infectious and serum hepatitis should be made compulsorily notifiable in all countries as soon as circumstances permit."

Published on: 25 July, 2024

The Advisory Group on Hepatitis and the Treatment of Chronic Renal Failure (known as the Rosenheim Committee) published the "Hepatitis and the Treatment of Chronic Renal Failure: Report of the Advisory Group 1970-1972". The Advisory Group was convened in 1970 by the DHSS to make recommendations in relation to hepatitis outbreaks in renal units.

Published on: 25 July, 2024

The PHLS authored the journal article "Decrease in the Incidence of Hepatitis in Dialysis Units associated with Prevention Programme" that was published in the "British Medical Journal".

Published on: 25 July, 2024

A letter to the Editor on primary pneumocystis carinii and cytomegalovirus infections was published by R M Du Bois et al in "The Lancet", reporting the first AIDS case in a British patient.

Published on: 25 July, 2024

Dr Galbraith wrote to venereologists and dermatologists in England and Wales seeking their "cooperation" in a trial clinical reporting system of Kaposi's sarcoma due to the "inadequacies of existing surveillance systems".

Published on: 25 July, 2024

Dr Galbraith wrote a letter to Dr Rizza of the Oxford Haemophilia Centre regarding the surveillance of AIDS and Kaposi's sarcoma.

Published on: 25 July, 2024

Dr Rizza responded to Dr Galbraith, communicating his awareness of the CDSC's surveillance scheme from discussions with Dr Craske and readiness to "do all we can to help you with your surveillance".

Published on: 25 July, 2024

A letter to the Editor on acquired immune deficiency syndrome authored by O'Connor et al was published in the "British Medical Journal", asking all doctors to let CDSC know when a patient with AIDS or Kaposi's sarcoma came under their care.

Published on: 25 July, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2087
  • Page 2088
  • Page 2089
  • Page 2090
  • Current page 2091
  • Page 2092
  • Page 2093
  • Page 2094
  • Page 2095
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.